HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Y Murata Selected Research

Adenocarcinoma

5/2006Comparison of the immunophenotypes of signet-ring cell carcinoma, solid adenocarcinoma with mucin production, and mucinous bronchioloalveolar carcinoma of the lung characterized by the presence of cytoplasmic mucin.
7/2001Impaired FHIT expression characterizes serous ovarian carcinoma.
10/2000Chorioamnionitis decreased incidence of respiratory distress syndrome by elevating fetal interleukin-6 serum concentration.
2/2000fhit Alterations in endometrial carcinoma and hyperplasia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Y Murata Research Topics

Disease

8Neoplasms (Cancer)
11/2018 - 01/2000
5Pre-Eclampsia (Preeclampsia)
01/2010 - 09/2000
4Atherosclerosis
09/2014 - 05/2000
4Adenocarcinoma
05/2006 - 02/2000
4Carcinoma (Carcinomatosis)
11/2005 - 01/2000
3Fatty Liver
11/2018 - 11/2000
3Disseminated Intravascular Coagulation
11/2018 - 07/2001
3Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)
11/2014 - 01/2000
3Infections
04/2014 - 04/2000
3Wounds and Injuries (Trauma)
04/2014 - 01/2000
3Body Weight (Weight, Body)
03/2013 - 01/2005
3Choriocarcinoma
02/2007 - 02/2000
3Proteinuria
10/2006 - 03/2001
3Endometriosis
10/2005 - 04/2000
3Ascites
10/2005 - 04/2000
3Inflammation (Inflammations)
03/2004 - 12/2000
3Breast Neoplasms (Breast Cancer)
06/2001 - 11/2000
2Ischemia
11/2018 - 08/2001
2Pleural Effusion (Pleural Effusions)
10/2017 - 04/2000
2Hypertension (High Blood Pressure)
05/2016 - 10/2006
2Pathologic Constriction (Stenosis)
05/2016 - 12/2001
2Thrombosis (Thrombus)
05/2016 - 03/2012
2Type 2 Diabetes Mellitus (MODY)
03/2013 - 05/2012
2Pain (Aches)
04/2012 - 11/2005
2Neural Tube Defects (Exencephaly)
05/2009 - 03/2009
2Obesity
01/2005 - 04/2000
2Hypertrophy
01/2005 - 02/2001
2Hyperplasia
01/2005 - 02/2000
2Leukemia
11/2001 - 05/2000
2Hypothermia
10/2001 - 08/2001
2Sarcoidosis (Schaumann Disease)
10/2001 - 02/2001
2Panuveitis
10/2001 - 02/2001
2Uveomeningoencephalitic Syndrome (Vogt Koyanagi Harada Syndrome)
10/2001 - 02/2001
2Autoimmune Diseases (Autoimmune Disease)
10/2001 - 09/2000
2Hypoxia (Hypoxemia)
08/2001 - 10/2000
2Brain Diseases (Brain Disorder)
06/2001 - 05/2000
2Collagen Diseases (Collagen Disease)
03/2001 - 08/2000
2Fibrosis (Cirrhosis)
03/2001 - 11/2000
2Chorioamnionitis
12/2000 - 10/2000
2Vitreous Detachment (Posterior Vitreous Detachment)
12/2000 - 11/2000
1Reperfusion Injury
11/2018
1Abscess
11/2018
1Lymphoproliferative Disorders (Lymphoproliferative Disorder)
11/2018
1Fever (Fevers)
11/2018
1Biliary Fistula
11/2018
1Back Pain (Backache)
11/2018
1Abdominal Abscess
11/2018
1Atrophy
11/2018
1Mycoses (Diseases, Fungus)
11/2018
1Clostridium Infections
12/2017
1Nasopharyngitis
08/2017
1Atopic Dermatitis (Atopic Eczema)
08/2017
1Liver Diseases (Liver Disease)
05/2016
1Hepatitis B
05/2016

Drug/Important Bio-Agent (IBA)

8Proteins (Proteins, Gene)FDA Link
12/2006 - 01/2000
3Immunoglobulin G (IgG)IBA
10/2017 - 02/2001
3AntigensIBA
12/2015 - 04/2000
3CholesterolIBA
04/2008 - 12/2000
3Tissue Plasminogen Activator (Alteplase)FDA Link
01/2008 - 07/2001
3Messenger RNA (mRNA)IBA
12/2006 - 10/2000
3Cisplatin (Platino)FDA LinkGeneric
08/2003 - 08/2000
3Protein Kinases (Protein Kinase)IBA
12/2001 - 01/2000
3Histamine (Histamine Dihydrochloride)FDA Link
11/2001 - 05/2000
3fragile histidine triad proteinIBA
07/2001 - 01/2000
3TamoxifenFDA LinkGeneric
06/2001 - 11/2000
2Pharmaceutical PreparationsIBA
11/2018 - 02/2001
2Indicators and Reagents (Reagents)IBA
11/2018 - 12/2000
2Immunoglobulins (Immunoglobulin)IBA
10/2017 - 05/2016
2LipidsIBA
09/2014 - 04/2000
2Sitagliptin Phosphate (Januvia)FDA Link
03/2013 - 05/2012
2Caspase 3 (Caspase-3)IBA
02/2013 - 08/2001
2Streptozocin (Streptozotocin)FDA Link
05/2009 - 03/2009
2Interleukin-4 (Interleukin 4)IBA
12/2003 - 09/2001
2DNA (Deoxyribonucleic Acid)IBA
12/2003 - 03/2001
2Fluorouracil (Carac)FDA LinkGeneric
08/2003 - 08/2000
2Estrogens (Estrogen)FDA Link
12/2001 - 04/2000
2Neuroprotective AgentsIBA
10/2001 - 08/2001
2Complementary DNA (cDNA)IBA
10/2001 - 02/2001
2AutoantigensIBA
10/2001 - 02/2001
2AutoantibodiesIBA
10/2001 - 02/2001
2InterleukinsIBA
06/2001 - 12/2000
2Histidine (L-Histidine)FDA Link
02/2000 - 01/2000
2beta CateninIBA
01/2000 - 01/2000
1polyglucosanIBA
11/2018
1ThrombomodulinIBA
11/2018
1CB-183,315IBA
12/2017
1VancomycinFDA LinkGeneric
12/2017
1Monoclonal AntibodiesIBA
08/2017
1Ustekinumab (CNTO 1275)FDA Link
08/2017
1Interleukin-12 (IL 12)IBA
08/2017

Therapy/Procedure

13Therapeutics
09/2014 - 04/2000
7Liver Transplantation
11/2018 - 03/2012
2Aftercare (After-Treatment)
11/2018 - 03/2001
2Cesarean Section (Caesarean Section)
01/2010 - 06/2003
2Intra-Arterial Infusions
11/2005 - 08/2003
2Chemoradiotherapy
08/2003 - 08/2000
2Radiotherapy
09/2001 - 02/2001
2Estrogen Replacement Therapy
05/2001 - 01/2001
1Catheters
11/2018
1Hepatectomy
11/2018